Table 4.
Comparison in cancer cachexia between male and female patients
Cachexia | |||
---|---|---|---|
Male (n = 50) | Female (n = 24) | p | |
Ages (years) | 65.32 ± 1.24 | 62.83 ± 2.42 | 0.313 |
BMI (kg/m2) | 22.26 ± 0.47 | 21.65 ± 0.67 | 0.461 |
HB (g/L) | 115.6 ± 3.92 | 103.8 ± 3.99 | 0.067 |
WBC (10^9/L) | 6.13 ± 0.31 | 5.92 ± 0.40 | 0.697 |
PLT (10^9/L) | 259.1 ± 14.07 | 271.1 ± 21.73 | 0.637 |
LY (10^9/L) | 1.40 ± 0.08 | 1.55 ± 0.09 | 0.295 |
TP (g/L) | 63.15 ± 0.88 | 65.52 ± 1.72 | 0.179 |
ALB (g/L) | 39.31 ± 0.66 | 38.81 ± 1.08 | 0.686 |
PA (g/L) | 0.186 ± 0.008 | 0.178 ± 0.011 | 0.557 |
TC (mmol/L) | 3.84 ± 0.12 | 4.13 ± 0.18 | 0.191 |
TG (mmol/L) | 1.216 ± 0.07 | 1.241 ± 0.14 | 0.858 |
ApoA (g/l) | 202.1 ± 25.81 | 246.2 ± 51.42 | 0.395 |
ApoB (g/l) | 0.84 ± 0.04 | 0.87 ± 0.05 | 0.648 |
ApoE (g/l) | 34.64 ± 1.49 | 41.38 ± 2.57 | 0.019 |
FFA (pg/ml) | 0.43 ± 0.03 | 0.56 ± 0.06 | 0.029 |
IL-6 (pg/ml) | 7.47 ± 1.05 | 7.55 ± 1.25 | 0.961 |
TNF-α (pg/ml) | 7.65 ± 0.42 | 8.74 ± 0.71 | 0.171 |
(I + II) TNM stage no. (%) | 16 (32.0%) | 8 (33.3%) | 0.909 |
BMI Body mass index, HB Hemoglobin, WBC White blood cell count, PLT Platelet, LY Lymphocyte count, TP Total protein, ALB Albumin, PA Prealbumin, TC Total cholesterol, TG Tri-glyceride, ApoA Apolipoprotein A, ApoB Apolipoprotein B, ApoE Apolipoprotein E, FFA Free fatty acid